• Business segment: Strategic & Operational Services for Drug & Device Development
  • Am Klopferspitz 19
  • 82152 Planegg/Martinsried
  • Deutschland
Simone Ahrens-Mende und Dr.

Simone Ahrens-Mende, Director DM & Biostatistics
Dr. Christoph Kapitza, Managing Director


KLIFO is an integrated North-European drug development consultancy with significant experience in partnering with biotech and pharmaceutical companies. We enable our partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement.

We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance in relation to the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution.

What is your motivation?

With offices in Denmark, Germany, Sweden and the Netherlands, and more than 200 highly qualified staff, all with solid industry experience, we can assemble a team of experts to support the efficient advancement of your project. No matter the phase, scale or therapy area, our experts can help plan, manage and execute your drug development project. Whether your organisation is challenged with time, resources or expertise, we can assemble a team of relevant expert consultants to assist you. We partner with international companies across the biotech and pharmaceutical industries and we are motivated by supporting our clients in achieving efficient project advancement.

“IZB is the location for the biotech start-ups that can greatly profit from our services. We look forward to helping them be successful.”

Dr. Christoph Kapitza, Managing Director
Simone Ahrens-Mende, Director DM & Biostatistics